— Know what they know.
Not Investment Advice

SYVC OTC

Synovics Pharmaceuticals, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 50 · $2983 mcap · 13M float · 0.0022% daily turnover

Balance Sheet Trends

Total Assets
$22M -4.2% ▼
5Y CAGR: +58.8%
Total Liabilities
$17M -44.8% ▼
5Y CAGR: +36.1%
Shareholders Equity
$5M +161.7% ▲
Cash & Investments
$66K +0.0% ▲
5Y CAGR: +83.7%
Total Debt
$7M -65.0% ▼
Net Debt
$6M -65.4% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2004FY2005FY2006FY2007FY2008
— Assets —
Cash$629K$129K$2M$0$66K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$629K$129K$2M$0$66K
Net Receivables$0$0$2M$3M$4M
Inventory$49K$4K$2M$2M$3M
Other Current Assets$0$0$0$0$0
Total Current Assets$701K$270K$8M$6M$7M
Property, Plant & Equip.$3K$5K$2M$2M$2M
Goodwill & Intangibles$724K$15M$27M$13M$12M
Long-Term Investments$1M$0$0$0$0
Other Non-Current Assets$0$2M$2M$3M$786K
Total Non-Current Assets$2M$17M$31M$18M$15M
Total Assets$3M$17M$39M$23M$22M
— Liabilities —
Accounts Payable$2M$1M$3M$5M$6M
Short-Term Debt$0$3M$6M$13M$3M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$1M$0$0-$1$383K
Total Current Liabilities$4M$6M$13M$25M$14M
Long-Term Debt$0$1M$12M$5M$4M
Other Non-Current Liab.$0$0$0$847K$0
Total Non-Current Liabilities$0$1M$13M$6M$4M
Total Liabilities$2M$6M$26M$31M$17M
— Equity —
Common Stock$16K$23K$26K$30K$38K
Retained Earnings-$42M-$45M-$53M-$74M-$79M
Accumulated OCI$0$512K$4M$5M$9M
Total Stockholders Equity$905K$11M$13M-$8M$5M
Total Liabilities & Equity$3M$17M$39M$23M$22M
— Key Metrics —
Total Debt$0$4M$18M$19M$7M
Net Debt-$629K$4M$15M$19M$6M
Total Investments$1M$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms